SEBI denies Glenmark Life Sciences’ request for no-action relief, stating contra trade restrictions apply to its proposed share sale for minimum public shareholding compliance.
SEBI provides informal guidance to CMS Info Systems on promoter disclosures and nominee shareholder roles under LODR and ICDR regulations.
SEBI clarifies Schedule II of Intermediaries Regulations, distinguishing applicability of fit and proper criteria for corporate entities vs. individuals under clause 3(b).
SEBI advises entities to seek approvals only via formal communication and follow the Informal Guidance Scheme for policy clarifications.
Mumbai Customs’ advisory clarifies Customs Brokers’ liability in interpretative disputes, emphasizing evidence of wrongdoing for penalties.
Clarification on refund of employee’s NPS share for death or disablement cases under CCS rules before notification of NPS Rules, 2021. Returns and contributions explained.
SEBI issues an interpretive letter clarifying related party transaction thresholds for Bajaj Finserv’s subsidiary, impacting insurance and re-insurance agreements.
No restrictions on joint bank accounts or nominations for the queer community, as clarified by the Supreme Court and RBI in August 2024.
MHA issues a public advisory warning against fake emails and documents in the name of FCRA officials. Always use the official FCRA portal for services and payments.
SEBI issues an interpretative letter to Belstar Microfinance Limited regarding compliance with SEBI’s Non-Convertible Securities Regulations, 2021.
